You are here: Home Published Research Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.

Marcelo C Scotta, Tiago N Veras, Paula C Klein, VirgĂ­nia Tronco, Fernando P Polack, Rita Mattiello, Paulo MC Pitrez, Marcus H Jones, Renato T Stein, and Leonardo A Pinto (2014)

Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.

Vaccine, 32(35):4495–4499.

Pneumococcal disease is a major public health problem worldwide. From March to September of 2010, 10-valent pneumococcal non-typeable Haemophilus influenzae protein conjugate vaccine (PHiD-CV) was introduced in the Brazilian childhood National Immunization Program (NIP) in all 27 Brazilian states. The aim of the present study is to report national time-trends in incidence of hospital admissions for childhood pneumonia in Brazil before and after two years of introduction of this new pneumococcal conjugate vaccine.

Brazil, Child, Preschool, Female, Haemophilus Infections, Health Policy, Hospitalization, Humans, Immunization Programs, Incidence, Infant, Infant, Newborn, Male, Pneumococcal Vaccines, Pneumonia, Pneumococcal, Retrospective Studies
Brazil, Child, Preschool, Female, Haemophilus Infections, Health Policy, Hospitalization, Humans, Immunization Programs, Incidence, Infant, Infant, Newborn, Male, Pneumococcal Vaccines, Pneumonia, Pneumococcal, Retrospective Studies
 
Document Actions